Monitor for any further 13G amendments or a potential conversion to a 13D if T. Rowe Price's investment strategy shifts from passive to active. The increase is consistent with a large asset manager adjusting its position and does not signal a change in investment thesis.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $1.30entry
- T+1 · 8d ago +15.38%α +13.02% · $1.50
- T+5 · 4d ago −1.54%α −4.13% · $1.28
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
T. Rowe Price Investment Management filed an amended Schedule 13G for Cabaletta Bio, reporting beneficial ownership of 28,138,417 shares (13.1% of common stock) as of October 31, 2026, up from 17,250,098 shares (8.0%) as of September 30, 2026. This is a routine passive stake increase by a large asset manager and has no material directional impact.
Key Financial Metrics
Key Facts
- T. Rowe Price Investment Management reported beneficial ownership of 28,138,417 shares of Cabaletta Bio common stock as of October 31, 2026.
- The stake represents 13.1% of the outstanding common stock.
- This is an amendment to a Schedule 13G, indicating passive investment intent.
- The filing was made pursuant to Rule 13d-1(b).
- T. Rowe Price Small-Cap Value Fund holds 15,367,961 shares (7.1%) of the class reported.
Financial Impact
T. Rowe Price increased its stake from 17,250,098 shares (8.0%) to 28,138,417 shares (13.1%), an increase of approximately 10,888,319 shares.
Risk Factors
- No material risks identified from this routine passive stake filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001897612-26-000706 |
| Document: 0001897612-26-000706-index.html | 0001897612-26-000706 |
| Document: 0001897612-26-000706.txt | 0001897612-26-000706 |
Track record
29 reports on CABA
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +31.59% at T+60 after the May 4, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $1.15 Now $1.11 −3.09% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.32 Now $1.11 −15.91% settles Nov 23
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $1.33 Now $1.11 −16.54% settles Nov 19
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $1.45 Now $1.11 −23.45% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Viewing Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $1.28 to $1.33 Now $1.11 −13.28% ▲ +3.91% +0.62% vs SPY
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers